Sanford Burnham Prebys welcomes two new members to its board of directors - Sanford Burnham Prebys
Press Release

Sanford Burnham Prebys welcomes two new members to its board of directors

AuthorCommunications
Date

November 17, 2026

Sanford Burnham Prebys Medical Discovery Institute has added two new and distinguished members to its board of directors: Bob Bolinger and Anne Bang

“I am delighted to welcome Bob and Anne to the board. Their combination of a new and fresh perspective with a deep understanding of the institute and biomedical research will be invaluable,” said David Brenner, MD, president and CEO of Sanford Burnham Prebys.

Since 2020, Bolinger has been a partner at CSBimpact, a San Diego-based marketing and media management agency founded by Mike Stafford and Bob Cerasoli in 2003. Previously, Bolinger enjoyed a long career in commercial radio, overseeing retail marketing, branding, promotion, and event marketing at Entercom, CBS Radio, Clear Channel Communications, KFMB AM/FM, and KKLQ AM/FM. 

He has served in advisory roles for Make-A-Wish San Diego, the Jacobs & Cushman San Diego Food Bank, YMCA of San Diego County, Sports San Diego, and Sharp HealthCare. 

Bolinger has a Bachelor of Science degree in psychology from Duke University. 

“It is an honor and a privilege to join the Sanford Burnham Presby Medical Discovery Institute board, and I am very grateful to (board chair) Lori Moore and David Brenner for this opportunity,” said Bolinger. 

“I hope to use my nonprofit board governance and marketing/media experience to enhance the cause and tell the story of the remarkable work this organization does.”

Bang succeeds Nick Cosford, PhD, as the faculty representative on the board of directors.

She is an associate professor in the Center for Therapeutics Discovery and director of cell biology at the Conrad Prebys Center for Chemical Genomics at Sanford Burnham Prebys. Her research bridges human stem cell biology, neuroscience, and drug discovery to develop new approaches for understanding and treating neurological disease.

Bang trained as a developmental neurobiologist, studying the genetic and molecular mechanisms that control cell fate and nervous system patterning. She began working with human pluripotent stem cells in 2005 at ViaCyte (now Vertex), where she became director of stem cell research and led an interdisciplinary team developing stem-cell-derived pancreatic cells as a therapy for diabetes. Her work advanced the technology from differentiation and cell characterization through scaled manufacturing and IND-enabling studies, resulting in multiple patents.

Bang joined Sanford Burnham Prebys in 2010 to establish human pluripotent stem cell-based disease modeling and discovery programs at the Prebys Center. Her laboratory now develops scalable human cell models and quantitative phenotyping platforms to investigate neurological disease, identify therapeutic targets, and discover potential treatments. 

“I look forward to bringing my experience in both biotechnology and academic research to the board. I’m excited about Sanford Burnham Prebys’ future and the opportunities created by bringing disease-focused research centers together with cutting-edge technology centers,” said Bang. 

“These complementary strengths provide a strong foundation for translating our scientific discoveries into new treatments and improvements in human health.”


About Sanford Burnham Prebys
Sanford Burnham Prebys Medical Discovery Institute is an independent nonprofit biomedical research institute dedicated to understanding the fundamental biology of human health and disease, and translating discoveries into advances that improve lives.

For over five decades, our scientists have driven breakthroughs across cancer, neuroscience, and aging, as well as diseases of the heart, muscle, metabolism, and liver. Anchored by our NCI-designated Cancer Center, our research is strengthened by drug discovery capabilities, data science and artificial intelligence, and global collaborations that help move discoveries toward real-world impact.

A strong culture of collaboration, paired with a commitment to graduate education and training the next generation of scientists, brings together researchers, partners, and philanthropists in a shared mission to advance biomedical science and improve human health. Learn more at sbpdiscovery.org.